SGRY Stock Overview
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States.
Surgery Partners Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$43.74|
|52 Week High||US$69.58|
|52 Week Low||US$24.20|
|1 Month Change||9.16%|
|3 Month Change||-8.53%|
|1 Year Change||69.40%|
|3 Year Change||204.81%|
|5 Year Change||212.43%|
|Change since IPO||137.33%|
Recent News & Updates
Estimating The Fair Value Of Surgery Partners, Inc. (NASDAQ:SGRY)
In this article we are going to estimate the intrinsic value of Surgery Partners, Inc. ( NASDAQ:SGRY ) by taking the...
|SGRY||US Healthcare||US Market|
Return vs Industry: SGRY exceeded the US Healthcare industry which returned 19.1% over the past year.
Return vs Market: SGRY exceeded the US Market which returned 21.3% over the past year.
|SGRY Average Weekly Movement||8.2%|
|Healthcare Industry Average Movement||6.3%|
|Market Average Movement||5.9%|
|10% most volatile stocks in US Market||15.1%|
|10% least volatile stocks in US Market||2.2%|
Stable Share Price: SGRY is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: SGRY's weekly volatility (8%) has been stable over the past year.
About the Company
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
Surgery Partners Fundamentals Summary
|SGRY fundamental statistics|
Is SGRY overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SGRY income statement (TTM)|
|Cost of Revenue||US$1.68b|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.98|
|Net Profit Margin||-3.97%|
How did SGRY perform over the long term?See historical performance and comparison
Is Surgery Partners undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: SGRY ($43.74) is trading above our estimate of fair value ($40.03)
Significantly Below Fair Value: SGRY is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: SGRY is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: SGRY is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SGRY's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SGRY is overvalued based on its PB Ratio (5.1x) compared to the US Healthcare industry average (2.9x).
How is Surgery Partners forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SGRY is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).
Earnings vs Market: SGRY is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: SGRY's is expected to become profitable in the next 3 years.
Revenue vs Market: SGRY's revenue (9.9% per year) is forecast to grow slower than the US market (10.1% per year).
High Growth Revenue: SGRY's revenue (9.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: SGRY's Return on Equity is forecast to be low in 3 years time (1.7%).
How has Surgery Partners performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SGRY is currently unprofitable.
Growing Profit Margin: SGRY is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SGRY is unprofitable, and losses have increased over the past 5 years at a rate of 26.8% per year.
Accelerating Growth: Unable to compare SGRY's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SGRY is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.5%).
Return on Equity
High ROE: SGRY has a negative Return on Equity (4.06%), as it is currently unprofitable.
How is Surgery Partners's financial position?
Financial Position Analysis
Short Term Liabilities: SGRY's short term assets ($841.7M) exceed its short term liabilities ($540.5M).
Long Term Liabilities: SGRY's short term assets ($841.7M) do not cover its long term liabilities ($3.2B).
Debt to Equity History and Analysis
Debt Level: SGRY's net debt to equity ratio (124%) is considered high.
Reducing Debt: SGRY's debt to equity ratio has reduced from 266.8% to 141.7% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SGRY has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SGRY is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 13.4% per year.
What is Surgery Partners's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SGRY's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SGRY's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SGRY's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SGRY's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SGRY's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
J. Evans (43 yo)
Mr. J. Eric Evans has been the Chief Executive Officer and Director of Surgery Partners, Inc. since January 13, 2020 and served as its Executive Vice President and Chief Operating Officer since April 1, 20...
CEO Compensation Analysis
Compensation vs Market: J.'s total compensation ($USD3.54M) is below average for companies of similar size in the US market ($USD5.20M).
Compensation vs Earnings: J.'s compensation has been consistent with company performance over the past year.
Experienced Management: SGRY's management team is considered experienced (2.3 years average tenure).
Experienced Board: SGRY's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: SGRY insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 76.8%.
Surgery Partners, Inc.'s employee growth, exchange listings and data sources
- Name: Surgery Partners, Inc.
- Ticker: SGRY
- Exchange: NasdaqGS
- Founded: 2004
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: US$3.844b
- Shares outstanding: 87.89m
- Website: https://www.surgerypartners.com
Number of Employees
- Surgery Partners, Inc.
- 310 Seven Springs Way
- Suite 500
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/11/26 23:20|
|End of Day Share Price||2021/11/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.